Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | UT8873JA | OT / LA |
patient inadvertently received a second influenza vaccine this season with no reported adverse event; Initial information received on 27-Oct-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 5 years old female patient who inadvertently received second dose of Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone] this season with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Influenza Vaccine (Influenza Vaccine) for Immunisation on 10-Oct-2025. On 27-Oct-2025, the patient received an extra 0.5ml dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine (once), Suspension for injection, (unknown strength) lot UT8873JA and expiry date 30-Jun-2026 via intramuscular route in the left deltoid for immunisation, with no reported adverse event (extra dose administered) (Latency Same day). Reportedly, nurse reported a patient who was inadvertently administered a second dose of fluzone pre-filled syringe and asked if we had any information on patients receiving an extra dose and no other vaccines were administered concomitantly. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
INFLUENZA VACCINE